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High glucose concentration causes a rise in [Ca21]i of cardiac myo-
cytes. Diabetes mellitus is associated with an elevation in the basal levels
of cytosolic calcium ([Ca21]i) of cardiac myocytes. This may be due in part
to a glucose-induced elevation in [Ca21]i. The present study examined this
issue and explored the cellular pathways responsible for such a phenom-
enon. A total of 30 mM glucose, mannitol or choline chloride, but not urea,
induced a time- and dose-dependent rise in the [Ca21]i of cardiac
myocytes. G protein inhibition by GDPbS or pertussis toxin produced
significant inhibition ($ 80%) in the rise in [Ca21]i. Incubation of cardiac
myocytes in a calcium free medium or in media containing verapamil,
nifedipine or amlodipine almost completely abolished the rise in [Ca21]i,
while ryanodine produced only small reduction (10%) in the glucose-
induced rise in [Ca21]i. Rp-cAMP or H-89, inhibitors of the cAMP-
protein kinase A pathway, produced a modest decrease in the rise in
[Ca21]i, while staurosporine (an inhibitor of PKC) and HOE 694 (an
inhibitor of the Na1-H1 exchanger) had no effect on the rise in [Ca21]i.
The results indicate that the osmotic activity of glucose (cell shrinkage)
activates G protein(s), most likely through a stretch receptor, which in turn
stimulates calcium channels inhibitable by verapamil, nifedipine and amlo-
dipine, thus permitting a calcium influx into the cardiac myocytes. The
increased calcium entry may stimulate a calcium release from intracellular
stores by a calcium-induced calcium release process. Thus, in cardiac myo-
cytes direct activation of calcium channels, and to a small extent activation of
the cAMP-protein kinase A, and calcium-induced calcium release mediate
the high glucose-induced acute rise in their [Ca21]i.
Diabetes mellitus is associated with disturbances in cellular
calcium homeostasis of the myocardium [1–5]. Allo et al [5]
reported that the basal levels of cytosolic calcium ([Ca21]i) of
cardiomyocytes from non-insulin dependent diabetes mellitus
(NIDDM) rats are significantly elevated. Similar observations
were reported by Nakagawa et al [4] in mice with alloxan-induced
diabetes. An elevation in the basal levels of [Ca21]i of cells may
occur secondary to an increase in calcium influx into the cells
and/or a decrease in calcium exit from the cells.
Available data indicate that the activities of Na1-Ca21 ex-
changer and of Ca21ATPase are reduced in myocardial sarco-
lemma of rats with NIDDM [5]. Also Ca21ATPase activity of
sarcolemmal preparation of heart from rats with streptozotocin-
induced diabetes is impaired [2]. These data indicate that calcium
efflux from these cells is impaired in NIDDM and in insulin-
dependent diabetes mellitus (IDMM), and this defect is, at least
partly, responsible for the elevation in basal levels of [Ca21]i of the
cardiac myocytes in diabetes. Furthermore, Ca21 uptakes by cardiac
sarcoplasmic reticulum [3] and by cardiac mitochondria [1] are
impaired in streptozotocin-induced diabetes, indicating that the
buffering of calcium in the cytosol by intracellular structures is also
impaired. These derangements contribute to the elevation in the
basal levels of [Ca21]i of the cardiac myocytes in diabetes.
It is theoretically possible that diabetes mellitus is also associ-
ated with increased calcium influx into cardiac myocytes. This is
plausible since the exposure of many cells such as insulinoma cells
[6], pancreatic islets [7], vascular smooth muscle cells of rat tail
artery [8] and polymorphonuclear leukocytes [9] to a high glucose
concentration is associated with an acute rise in their [Ca21]i. It is
possible that a similar effect occurs in cardiomyocytes. The
present study examined this issue and explored the cellular
pathways that may lead to the acute rise in [Ca21]i of cardiac
myocytes exposed to high glucose concentrations.
METHODS
A total of 78 male Sprague-Dawley rats weighing 200 to 260 g
(239 6 3.5 g) were used. They were fed normal rat chow diet
(Wayne Research Animal Diets, Bartonville, IL, USA) and
allowed to drink water ad libitum. Ventricular cells were isolated
using a modification of the methods of DeYoung, Giannattasio
and Scarpa [10] and Haworth et al [11]. The rats were anesthe-
tized with intraperitoneal injection of pentobartial sodium deliv-
ered in 0.2 ml (0.01 g/100 g body wt). The sternum was cut, and
the heart was immediately removed and placed into cold (4°C)
balanced salt solution (BSS) containing (in mM): 130 NaCl, 3 KCl,
1.2 KH2PO4, 1 MgSO4, 1.25 CaCl2, 10 N-2-hydroxyethylpipera-
zine-N9-2-ethanesulfonic acid (HEPES), and 10 glucose. The
aorta was then cannulated, and the heart was perfused with
oxygenated calcium (1.25 mM) Joklik’s medium (Sigma Chemical,
St. Louis, MO, USA) supplemented with 10 mM Na HEPES and
10 mM glucose (pH 7.2) for ten minutes at 37°C. The heart was
then perfused with 55 ml calcium-free Joklik’s medium supple-
mented with 10 mM Na HEPES, 5.5 mM glucose, and 10 mM KCl
(pH 7.2) for an additional five minutes. Thereafter, 100 U/ml of
collagenase type II (Worthington Biochemicals, Freehold, NJ,
USA), 1 mg/ml hyaluronidase (Sigma), and 0.1% bovine serum
albumin (BSA, Sigma) were added to the perfusion media. After
30 to 40 minutes, CaCl2 (1.25 mM) was added to the perfusate, and
the perfusion was continued for five minutes. The heart was then
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removed from the perfusion system, the atria were discarded, and
the ventricles were cut into four pieces, teased into strands, placed
in the same medium used in the last perfusion (calcium-Joklik’s),
and digested for additional five minutes. The cells suspension was
filtered through a 250-mm mesh Nitex screen (Tetko, Elmsford,
NY, USA) and washed twice by centrifugation at 100 g for one
minute with calcium Joklik’s media (pH 7.4). To purify the
myocytes, 45% Percoll step gradient (500 g, 2 min in swinging
bucket centrifuge) was used. All the supernatant and the Percoll
layer were discarded. The pellet was removed and washed again
with calcium Joklik’s medium by centrifugation.
The morphology of the myocytes was evaluated with an in-
verted light microscope. Healthy cells were rod shaped with clear
striations and are noncontracting in 1.25 mM calcium Joklik’s
medium. The viability of the cells assayed by trypan blue exclusion
test exceeded 90%. [Ca21]i of cardiac myocytes was measured by
Fura 2 AM using the Perkin-Elmer fluorometer model LS 5B
(Perkin-Elmer, Norwalk, CT, USA). The details of the method-
ology have also been reported from our laboratory [12]. Briefly,
fluorescence was measured at excitation wavelengths of 340 and
380 nm, and emission wavelength of 510 nm. The cells were lysed
with Triton-X (0.05%) to obtain Fmax. This concentration of
Triton-X does not produce fluorescence. Next, 10 ml of 0.5 M
ethyleneglycobis(b-aminoethylether)-N,N,N9,N9-tetraacetic acid
(EGTA) in 3 M tris (hydroxymethy) amino-methane (Tris) base
buffer (pH 8.5) were added to obtain Fmin. The myocytes were
washed before each study, and the above-mentioned calibration for
the fura 2 signal was performed after each study. To eliminate the
effects of autofluorescence due to the cuvette, medium, and myo-
cytes, the fluorescence was measured with empty cuvette after
addition of medium and after addition of cells without fura 2. The
unloaded myocytes did not generate fluorescence. Correction for the
autofluorescence of the cuvette and medium was made by setting the
fluorometer on autozero before each measurement. Calculation
[Ca21]i was made using the Grynkiewicz equation [13]. The dissoci-
ation constant for Ca21-fura 2 was assumed to be 225 nM.
It is theoretically possible that a high glucose concentration
disrupts the myocytes and leads to the release of fura 2 into the
media, and hence causes a rise in fluorescence. To rule out this
possibility we utilized the procedure reported by Dubyak and De
Young [14]. Unloaded myocytes were incubated with ethidium
bromide at 37°C for two minutes before and after exposure with
30 mM glucose for 5 and 10 minutes, since most studies were done
for this period of time. Fluorescence was measured at 365 nm
excitation and 588 nm emission wavelengths. We found that high
glucose concentration did not produce significant increments in
the relative fluorescence, which was 49 6 1.1 before and 50 6 0.9
after 10 minutes of exposure to 30 nM glucose.
We also examined the effect of time on [Ca21]i of the cardiac
myocytes and found that the values at 0 time and after 10 minutes
of incubation of cells in media containing 5.5 mN glucose were not
different (64 6 2.5 nM vs. 66 6 1.8 nM). Also, the increments in
[Ca21]i after the exposure to to 35 nM KCl at 0 time and after 10
minutes in cells incubated in a media containing 5.5 mM glucose
were not different (88 6 3.6 nM and 92 6 3.8 nM, respectively).
The rise in [Ca21]i in response to KCl in cells incubated for 10
minuted in a media containing 30 mM glucose was 88 6 3.3 nM;
this increment in [Ca21]i in response to KCl was not different
from that observed in cells incubated in 5.5 mM glucose media.
Mannitol, choline chloride, urea, verapamil, nifedipine, stauro-
sporine, guanosine 59-0-(2 thiodiphosphate) (GDPbS), and per-
tussis toxin were purchased from Sigma Company (St. Louis, MO,
USA); N- [2Cp-bromocinnamyl]ethyl]-5-isoquinoline sulfonaurae
(H-89) from Biomal Research Laboratory (Plymonth Meeting,
PA, USA); ryanodine from ICN Biochemicals (Irvine, CA, USA);
and Rp-cAMP for Calbiochem (La Jolla, CA, USA). Amlodipine
was a gift from Pfizer Inc. (New York, NY, USA). Mannitol,
choline chloride, urea, pertussis toxin, and GDPbS were dissolved
in water; verapamil, amlodipine, staurosporine, H-89 and Rp-
cAMP were dissolved in dimethyl sulfoxide, and nifedipine in
ethanol and then the entire solution diluted with water to obtain
the required concentration. The media for studies in the presence
of calcium contained 1 mM of this cation, while the media for the
studies in the absence of calcium (free calcium media) did not
contain CaCl2, but had 0.01 mM EGTA.
Data are presented as mean 6 1 SE and statistical analysis was
done with paired and unpaired Student’s t-test.
RESULTS
The basal levels of [Ca21]i in the cardiac myocytes obtained from
all rats ranged between 57 to 83 nM with a mean of 68.7 6 0.77 nM.
These values are similar to those reported by us previously [12]. The
levels of [Ca21]i of the cells incubated in free calcium medium were
41 6 2.9 nM, a value significantly (P , 0.01) lower than that of cells
kept in a calcium containing medium, and were not different from
that (45 6 1.9 nM) reported by us previously [12].
The effects of the incubation of cardiac myocytes in media
containing 30 mM glucose, choline chloride, mannitol or urea on their
[Ca21]i are shown in Figure 1. Within five minutes after the exposure
of the cardiac myocytes to 30 mM glucose, their [Ca21]i (86 6 3.7 nM)
was significantly (P , 0.01) higher than the basal values obtained in
cells incubated in 5.5 mM glucose (67 6 3.0 nM) and increased further
Fig. 1. Effect of high concentrations of glucose (30 mM; F), choline
chloride (30 mM; f), mannitol (30 mM; ) and urea (30 mM; E) on the
[Ca21]i of cardiac myocytes. Each datum point represents the mean of six
to seven studies, and the brackets denote 6 1 SE.
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to 104 6 1.9 nM by 10 minutes. Similar effects were obtained with
choline chloride and mannitol but not with urea.
Figure 2 depicts the effect of various concentrations of glucose
on the [Ca21]i of cardiac myocytes. It is evident that there is a
dose-dependent effect between glucose concentration and [Ca21]i
both after 5 and 10 minutes.
An acute rise in [Ca21]i could be due to an increase in calcium
influx from the media, an acute release of calcium from intracellular
stores or both. We first examined the effect of various calcium
channel blockers on the rise in [Ca21]i induced by 30 mM glucose.
The cardiac myocytes were incubated for one minute in media
containing 5.5 mM glucose and the appropriate concentration of the
calcium channel blocker. Then glucose was added to raise its
concentration to 30 mM; [Ca21]i was measured 5 or 10 minutes later.
The results are depicted in Table 1. Verapamil (40 mM), nifedipine (4
mM) or amlodipine (4 mM) completely abolished the glucose-induced
rise in [Ca21]i of the cardiac myocytes. Similar concentrations of the
calcium channel blocker did not affect the [Ca21]i of these cells
incubated in a media containing 5.5 mM glucose.
We then evaluated the effect of 30 mM glucose on [Ca21]i of
cardiac myocytes incubated in media containing no calcium but
with 0.01 mM EGTA or in media containing calcium and ryano-
dine, an agent that depletes [15] and/or inhibits calcium release
[16], from intracellular stores. A total of 30 mM glucose failed to
increase the [Ca21]i of cardiac myocytes incubated in a calcium
free media. The basal values of [Ca21]i were 41 6 2.9 nM, and the
values were 42 6 2.2 nM and 45 6 2.4 nM after 5 or 10 minutes of
incubation, respectively. Figure 3 shows the effect of ryanodine on
the glucose-induced rise in [Ca21]i incubated in media containing
calcium. The agent caused small reduction (10%) in the magni-
tude of the glucose-induced rise in [Ca21]i.
We then examined whether the effect of high glucose on [Ca21]i
of cardiac myocytes is mediated through stimulation of a G pro-
tein(s). This was done by evaluating the effect of a G protein
inhibitor (GDPbS) and of pertussis toxin, an agent that prevents
receptor-mediated processes which utilize G protein [17], on the
glucose-induced rise in [Ca21]i. In the studies with GDPbS, various
concentrations of the agent (100, 200 and 300 mM) were added to the
media containing 5.5 mM glucose and cardiac myocytes, and one
minute later the glucose concentration in the media was increased to
30 mM. In the studies with pertussis toxin, the cardiac myocytes were
preincubated for 60 minutes at 37°C with 10 mg/ml of pertussis toxin
in a media containing 5.5 mM glucose; then the glucose concentration
was increased to 30 mM. The results of these studies are shown in
Figure 4. GDPbS produced a dose-dependent reduction in the
glucose-induced rise in [Ca21]i. The magnitude of the inhibitions
with 300 mM of GDPbS were 82 6 7.2% and 86 6 4.8% after 5 and
10 minutes, respectively. Similar effects were obtained with pertussis
toxin with the inhibition being 80 6 4.3% and 79 6 3.2% after 5 and
10 minutes, respectively.
Since activation of G protein(s) would stimulate the adenylate
cyclase-cAMP and phospholipase C pathways [17], we examined the
role of these systems in mediating the glucose-induced rise in [Ca21]i
in cardiac myocytes. Rp-cAMP, a competitive inhibitor of cAMP
binding to the R subunit of protein kinase A [18], produced a modest
Fig. 2. Effects of various concentrations of glucose on [Ca21]i of cardiac
myocytes at (E) five minutes and (F) ten minutes. Each datum point
represents the mean of six studies and the brackets denote 6 1 SE.
Table 1. Effects of verapamil, nifedipine or amlodipine on the
glucose-induced rise in cytosolic calcium of rat myocytes
Basal
Cytosolic calcium nM
5 minutes 10 minutes
30 mM glucose 68 6 3.5 83 6 2.6a 104 6 2.9a
30 mM glucose 6 40 mM verapamil 68 6 3.5 68 6 2.7 71 6 3.0
40 mM verapamil aloneb 70 6 1.3 72 6 1.7 74 6 4.1
30 mM glucose 6 4 mM nifedipine 68 6 3.5 69 6 3.3 73 6 4.0
4 mM nifedipine aloneb 70 6 3.0 71 6 3.1 74 6 4.0
30 mM glucose 6 4 mM amlodipine 68 6 3.5 69 6 2.6 75 6 4.1
Data are presented as mean 6 1 SE of six studies.
a P , 0.01 from basal as well as 5 and 10 minute values in all other
studies
b Media in these studies contained 5.5 mM glucose.
Fig. 3. Effect of ryanodine on the glucose-induced rise in [Ca21]i of
cardiac myocytes incubated in a media containing 1 mM calcium. Each
column represents the mean of six studies and brackets denote 6 1 SE.
Symbols are: (M) basal; (f) 1 mM Ca; (o) Ca 1 ryanodine 1027 M.
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inhibition of the rise in [Ca21]i (Fig. 5). A similar effect was observed
with H-89, an inhibitor of protein kinase A (Fig. 5) [19]. Staurospor-
ine, an inhibitor for protein kinase C [20], did not reduce the
glucose-induced rise in [Ca21]i. After five minutes of incubation the
levels of [Ca21]i of the cardiac myocytes incubated in media contain-
ing 30 mM glucose were only 75 6 1.7 nM and 74 6 1.7 nM when the
media had 1027 M staurosporine, and the values were 96 6 2.4 nM
and 95 6 2.3 nM after 10 minutes of incubation, respectively.
Similarly, HOE 694 (1025 M), an inhibitor of the Na1-H1
exchanger [21], did not affect the glucose-induced rise in [Ca21]i
of cardiac myocytes. The values of [Ca 21]i at 5 and 10 minutes
incubation of the cells in media containing 30 mM glucose were
80 6 1.1 nM and 80 6 1.1 nM, and 100 6 1.2 nM and 101 6 1.2 nM
without and with HOE 694, respectively.
DISCUSSION
The results of the present study show that a high glucose
concentration causes a time-dependent and a dose-dependent
acute rise in [Ca21]i of cardiac myocytes. Our findings show that
a high glucose concentration failed to raise [Ca21]i in cardiac
myocytes incubated in calcium free media, and that calcium
channel blockers prevented the glucose-induced rise in [Ca21]i in
the cells, and are consistent with the notion that the acute rise in
[Ca21]i is due to an increased calcium influx into these cells.
It is possible that a decrease in calcium exiting out of the cardiac
myocytes also contributed to the glucose-induced rise in [Ca21]i.
Indeed, others have reported that impairment in the various calcium
pumps was involved in calcium homeostasis in the heart in diabetes
mellitus [1–5], most likely due to glycosylation of transport proteins
[20, 21]. However, these studies differ in that the exposure of the
cardiac myocytes to a high glucose concentration in their diabetic
animals was prolonged while it was very short in our studies. It is
theoretically possible that even the short exposure of cardiac myo-
cytes to high glucose concentration may affect the calcium pump
involved in the regulation of calcium exiting out of these cells, and
partially contributes to the glucose-induced acute rise in their
[Ca21]i. We did not measure the activity of these pumps and,
therefore, our data cannot refute or support this possibility.
The results of our studies showing an acute glucose-induced rise
in [Ca21]i and those of others demonstrating decreased efflux and
impaired buffering of calcium by sarcoplasmic reticulum and
mitochondra [1–5, 20, 21] indicate that there are multiple mech-
anisms responsible for the elevation in basal levels of [Ca21]i in
the heart of diabetics [4, 5].
Glucose uptake by the myocardium is insulin dependent [24]. In
our studies the media did not contain insulin, and therefore, the
glucose-induced rise in [Ca21]i cardiac myocytes is not due to a
specific characterisitic of glucose or its metabolisms by these cells,
but is due to the osmotic effect of glucose that would cause
shrinkage. This conclusion is further supported by the observa-
tions that mannitol and choline chloride in molar concentrations
similar to those of glucose produced identical increments in the
[Ca21]i of cardiac myocytes, while 30 mM of urea, which pene-
trates the cells and does not cause shrinkage, did not induce a rise
in [Ca21]i. It could be argued that choline chloride is made of
non-cell penetrating cation and a penetrating anion, and thus the
osmotic activity of choline chloride across the sarcolemmal mem-
brane is unpredictable and may be different from that of glucose
or mannitol. Therefore, the similar effects of equimolar concen-
trations of choline chloride on [Ca21]i to those of glucose or
mannitol may cast some doubt on the notion that the effects of
these three compounds are due only to their osmotic activity. We
did not measure the actual sarcolemmal osmotic gradient induced
by these three compounds, nor determine the volume of cardiac
myocytes after their exposure to these compounds. However, in a
previous study we showed that the reductions in the volume of
polymorphonuclear leukocytes exposed to 30 mM of glucose or
choline chloride were not different [9]. This observation indicates
that osmotic activities of 30 mM of choline chloride or glucose are
not different. Furthermore, the renal proximal tubule cell re-
sponded in a smilar manner to 30 mM of glucose, choline chloride,
Fig. 4. Effects of various concentrations of the G protein inhibitor
(GDPbS) (A) and of pertussis toxin (B) on the glucose-induced rise in
[Ca21]i. Each column represents the mean of five to six studies and the
brackets denote 6 1 SE. Symbols in A are: (f) 30 mM glucose; (o) glucose
1 GDPbS 100 mM; (u) glucose 1 GDPbS 200 mM; (M) glucose 1 GDPbS
400 mM. Symbols in B are: (f) glucose 30 mM; (M) glucose 1 pertussis
toxin 10 m/ml.
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and mannitol in that all these compounds produced a similar
increment in the [Ca21]i of these cells [25].
Cells may possess stretch receptors that would be activated
during shrinkage or swelling of cells, leading to stimulation of
stretch activated channels [26–28] and/or various cellular path-
ways in order to add or reduce osmoles. As a result, the volume of
cells is restored. Certain data have shown that a G protein(s) is
involved in this process [29]. If such receptors are present in
cardiac myocytes, their stimulation by shrinkage of the cells
during the exposure to high glucose may result in the activation of
calcium channels and other cellular pathway that may lead to rise
in [Ca21]i. It has been shown that mechanical stretch activates
protein kinases of the myocardium [30], but no data are available
to prove or refute the presence of receptors responding to
shrinkage of cardiac myocytes. However, several observations in
our study are consistent with the notion that the exposure of
cardiac myocytes to a high glucose concentration results in the
stimulation of a G protein(s), activation of calcium channels and
stimulation of the adenylate cyclase-cAMP pathway.
Indeed, both the G protein inhibitor (GDPbS) and pertussis
toxin almost completely abolished the glucose-induced rise in
[Ca21]i, providing support for the proposal that the shrinkage of
cardiac myocytes is associated with activation of G protein(s). The
latter may modulate the activity of the calcium channels either
directly [31] or indirectly via the generation of cAMP [32, 33].
Our data clearly show that three calcium channel blockers that
inhibit voltage dependent (L-type) calcium channels, which are
present in the heart [34], completely abolished the rise in [Ca21]i.
These observations demonstrate that these channels are activated
by the exposure of the cardiac myocytes to a high glucose
concentration permitting calcium influx into these cells, and that
this inward calcium movement is responsible entirely for the rise
in [Ca21]i. Further support for this conclusion is provided by the
failure of high glucose concentration to raise the [Ca21]i of
cardiac myocytes when they were placed in a calcium-free media.
It is of interest that ryanodine, an agent that depletes [15] and/or
inhibits the release of calcium [16] from intracellular stores,
caused a small (10%) decrease in the magnitude of the glucose-
induced rise in [Ca21]i, suggesting that a small fraction of the total
rise in [Ca21]i is due to this phenomenon. However, since the rise
in [Ca21]i is completely blocked by calcium channel blocker, one
may conclude the small release of calcium from intracellular
stores in dependent on the calcium influx induced by high glucose
concentration and it is mediated by the calcium-induced calcium
release phenomenon [35].
The interference with the adenylate cylase-cAMP-protein ki-
nase A pathway, by Rp-cAMP or H-89, resulted in a modest
inhibition of the glucose-induced rise in [Ca21]i of cardiac myo-
cytes. This finding could be interpreted to indicate that this
cellular pathway is partially involved in the activation of the
calcium channels.
The activation of G protein(s) may also stimulate the phospho-
lipase C pathway with subsequent generation of IP3 and activation
of protein kinase C [17]. Indeed, glucose activates protein kinase
C in many cells [36–38] and activation of this enzyme causes a rise
in [Ca21]i in thymocytes [39], pancreatic islets [40], hepatocytes
[41], adipocytes [42], and renal proximal tubular cells [43]. Our
data, however, do not support a role for protein kinase C in the
genesis of the rise in [Ca21]i, since staurosporine, an inhibitor of
protein kinase C [20], did not affect the glucose induced rise in
[Ca21]i. Furthermore, previous studies have shown that activation
of protein kinase C by the phorbol ester, TPA, did not cause a rise
in [Ca21]i in cardiac myocytes [13]. Finally, HOE 694, an inhibitor
of the Na1-H1 exchanger [21], did not inhibit the glucose-induced
rise in [Ca21]i in cardiac myocytes.
Taken together, our data are consistent with the notion that
shrinkage of cardiac myocytes by their exposure to high osmotic
activity (glucose, mannitol or choline chloride) may activate a
sensor for cell shrinkage that would then stimulate a G protein
system(s). This is may be followed by the direct and indirect (via
cAMP) activation of calcium channels that permits calcium influx
into the cardiac myocytes. The contribution of the adenylate-
cyclase-cAMP-protein kinase A pathway to this process is modest.
The calcium influx into the cardiac myocytes may cause a small
Fig. 5. The effects of various concentrations of Rp-cAMP (A) an H-89 (B)
on the glucose-induced rise in [Ca21]i of cardiac myocytes. Each column
represents the mean of six studies and brackets denote 6 1 SE. Symbols in
A are: (f) 30 mM glucose; (o) glucose 1 Rp-cAMP 100 mM; (u) glucose
1 RP-cAMP 200 mM; (M) glucose 1 Rp-cAMP 400 mM. Symbols in B are:
(f) glucose 30 mM; (o) glucose 1 H-89 50 mM; (M) glucose 1 H-89 100 mM.
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release of calcium from their intracellular stores via the calcium-
induced calcium release phenomenon. This formulation is pre-
sented in Figure 6. It must be emphasized that this formulation is
a proposal and not intended to be definite.
The pathways described above in cardiac myocytes are different
from those that mediate a glucose-induced rise in [Ca21]i in
polymorphonuclear leukocytes [9]. In the latter cells, this phe-
nomenon is due to the activation of the adenylate cyclase-cAMP-
protein kinase A pathway, the phospholipase C system, calcium
channels and to a substantial degreee (50%) by the mobilization
of calcium from intracellular stores. It is of interest that parathy-
roid hormone, an agent that also causes a rise in [Ca21]i in many
cells, mediates its effect through multiple cellular pathways but
utilizes the direct activation of calcium channels almost entirely,
with a small contribution from the mobilization of intracellular
calcium in the case of myocardium [12, 44].
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